- Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study
Avner Ehrlich et al, 2023, eLife CrossRef - Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model
Felix B. Meyer et al, 2021, Biomolecules CrossRef - Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Hany S. Ibrahim et al, 2021, International Journal of Molecular Sciences CrossRef - Metformin alters therapeutic effects in the BALB/c tumor therapy model
Felix B. Meyer et al, 2021, BMC Cancer CrossRef - The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Zhimin Tang et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef - The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
Chang Liu et al, 2021, Frontiers in Oncology CrossRef - Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
Jinqing Wu et al, 2021, Gastroenterology Research and Practice CrossRef - Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
Hanjiao Qin et al, 2023, Frontiers in Pharmacology CrossRef - Loss of FBP1 by aPKC-ι/Snail Pathway-Mediated Repression Promotes Invasion and Aerobic Glycolysis of Intrahepatic Cholangiocarcinoma
Meng Gao et al, 2021, Frontiers in Oncology CrossRef - Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
Chin-Hsiao Tseng, 2020, Frontiers in Oncology CrossRef - Apoptotic and anti‐Warburg effect of Morusin via ROS mediated inhibition of FOXM1/c‐Myc signaling in prostate cancer cells
Ja Il Koo et al, 2023, Phytotherapy Research CrossRef